AstraZeneca Unpacks Why Vaccine Effectiveness Is Never One Factor: 2D Animation Explainer
Last updated on June 25, 2026
MyPromoVideos builds 2D animation explainers for pharma and healthcare brands that need to make complex science accessible to a non-specialist audience. Get a quote in one click.
Get a Quote for a Video Like This →| Category | Details |
| Featured Brand | AstraZeneca (global biopharmaceutical company, listed on the London Stock Exchange, with a focus on oncology, rare diseases, and infectious disease vaccines) |
| Industry | Healthcare / Pharmaceutical Science Communication |
| Video Style | 2D Animation |
| Video Type | Science Communication Explainer |
| Estimated Length | 1 minute 36 seconds |
| Target Audience | Pharmaceutical science communicators, public health educators, and healthcare marketing managers explaining vaccine science to non-specialist audiences |
| Primary Goal | Show why vaccine effectiveness involves multiple interconnected scientific factors rather than one single metric, using layered 2D animation for a non-specialist global audience |
This 96-second 2D animation explainer by AstraZeneca shows why vaccine effectiveness involves multiple interconnected factors rather than one single metric. The video targets pharmaceutical science communicators, public health educators, and healthcare marketing managers explaining vaccine science to non-specialist audiences. Consequently, viewers leave with a framework for structuring a multi-factor health science concept into one layered 2D animation narrative.
Inside This Video
If you are briefing a 2D animation explainer on vaccine science, the hardest challenge is making interconnected factors feel like one clear story. A health explainer that lists factors in sequence risks losing the viewer before the key message lands. AstraZeneca solves that brief in 96 seconds by treating vaccine effectiveness as an interconnected system, not a checklist. Browse our 2D animation video examples or contact a B2B video production company to brief a science communication explainer in this format.
The animation uses a layered visual structure to show that vaccine effectiveness is not one factor but many working together. Specifically, the video maps how each variable connects to the others rather than presenting them as a numbered list. In contrast to a static slide deck, 2D animation lets the viewer follow those connections as a moving visual system. Additionally, MyPromoVideos applies this system-mapping approach when briefing pharma and healthcare science communication explainers; see MyPromoVideos B2B video case studies to review comparable work.
What Makes This Video Stand Out?
- System map over sequential checklist: Most science explainers present factors in numbered sequence: first this, then that. This 2D animation treats vaccine effectiveness as a system where the factors influence each other. Specifically, the viewer sees the connections rather than a list. That structural choice removes the risk of oversimplifying a genuinely complex topic.
- 96 seconds for a multi-factor science topic: Covering multiple interconnected factors in under 2 minutes is a brief discipline, not a format compromise. 2D animation removes the need for spoken transitions between points that live-action explainers often require. In contrast, the visual system links each factor in real time. That runtime discipline is a production decision as much as a topic depth decision.
- Science communication without clinical jargon: The video explains a complex immunology concept to a non-specialist audience. This is where 2D animation earns its place: the visual metaphor works where clinical terminology fails. Therefore, the viewer understands vaccine effectiveness as a network of factors without needing prior immunology knowledge. That accessibility is the brief outcome, not a simplification.
- Education-led brand positioning, no product claims: The video makes no product claim and names no AstraZeneca vaccine by brand name. It positions the company as a source of public health education rather than a product promoter. Consequently, the science communication content builds brand trust in a category where trust is the primary purchase variable. For pharma brands, that positioning choice is a brief decision.
- Global audience design as a production constraint: Vaccine effectiveness matters across geographies and medical literacy levels. The 2D animation brief treats that audience breadth as a design constraint, not a simplification. As a result, the video works as a global health communication asset rather than a market-specific product push. For pharma brands operating across markets, that brief choice affects long-term content strategy.
Want a 2D animation explainer that makes your pharma or healthcare science accessible to a non-specialist audience? MyPromoVideos builds them script-first. Book a free strategy call to discuss your brief.
Book a Free Strategy Call →4 Decisions Worth Copying From This Video
These four production decisions from AstraZeneca's 96-second vaccine effectiveness explainer each solve a brief problem that appears regularly in science communication work.
Map Factor Relationships Before Scripting
Science explainers default to numbered lists. A system map shows the connections between factors, which is what this video does. In a 2D animation explainer brief, ask the team to draw the factor relationships first, before writing the script sequence. That mapping step determines whether the video teaches comprehension or recall.
Education-Led Positioning for Pharma Brands
Explaining a complex health topic clearly without a product claim positions the brand as an authority. AstraZeneca uses this video to present itself as a science educator rather than a product advertiser. Additionally, that positioning builds brand trust, which is more durable than a campaign preference. For pharma brands, this approach applies to any complex health topic.
2D Animation as Complexity Reducer
2D animation handles multi-factor science topics better than live action because it shows abstractions visually. In this video, the animation converts vaccine science complexity into a navigable visual system. Specifically, abstract concepts like immune response and disease transmission become shapes and connections a non-specialist can follow. For science communication briefs, that visual translation is the core production job.
System Mapping Earns the 96-Second Runtime
A 96-second runtime covers multiple interconnected vaccine factors when the visual structure does the linking work. The brief decision is whether to sequence factors one by one or map them as a system. In other words, this video earns its runtime efficiency by mapping rather than listing the science. For science communication explainers, 90 to 120 seconds is the right brief target with this approach.
When to Use 2D Animation for Your Business Video
AstraZeneca's vaccine brief shows exactly when a B2B video production company recommends 2D animation over live action for science communication content.
Science Communication and Public Health
2D animation handles abstract health topics with multiple interconnected components. The format makes invisible processes visible without requiring live-action footage of a laboratory or clinical setting.
Multi-Factor Explainer Content
When the brief has six or more variables that interact, 2D animation shows the relationships visually. A slide deck or static infographic cannot show the dynamics; 2D animation can.
Brand Authority in Technical Categories
Pharma and healthcare brands use 2D animation to build science communication credibility without making product claims. The format suits any brief where education builds more long-term trust than advertising.
Emotional Patient Stories
When the brief depends on patient testimony or the emotional weight of a real human story, live action is more credible. 2D animation builds cognitive understanding; live action builds emotional connection.
Production Duration
A 90 to 120-second 2D animation science explainer typically takes six to ten weeks from an approved brief to delivery. The most common delay is scientific fact-checking cycles after the first animatic.
Product Feature Demos
When the brief is a feature demo where the product interaction must be shown exactly as it works, live action or screen recording is more credible. 2D animation suits concept explanation, not precise UI demonstration.
Why 2D Animation Works for B2B Marketing
2D animation lets a pharma brand like AstraZeneca map complex multi-factor science into a visual system a non-specialist audience can follow. Consequently, the format earns its place where text or live action would lose the viewer to complexity. Browse our 2D animation video examples for more video inspiration, or see MyPromoVideos B2B video case studies for comparable health explainers.
Frequently Asked Questions
What makes 2D animation the right format for explaining vaccine effectiveness to a non-specialist audience?
2D animation handles multi-factor science topics better than live action or text because it shows abstract relationships visually. Vaccine effectiveness involves factors like immune response, population immunity, and disease transmission that are difficult to film directly. Specifically, 2D animation converts those abstractions into moving shapes and connected pathways a non-specialist audience can follow. That visual translation is the core advantage of 2D animation for pharma science communication briefs.
How should a pharma brand structure a 2D animation explainer covering multiple vaccine effectiveness factors?
The key script decision is whether to sequence the factors one by one or map them as an interconnected system. AstraZeneca's vaccine effectiveness explainer uses the second approach: the video shows how each factor connects to the others rather than presenting them as a numbered list. In other words, the structure treats vaccine effectiveness as a network, which lets viewers absorb connections rather than memorise individual points. For pharma science briefs with multiple variables, system mapping is the more effective script structure.
When should a healthcare company use 2D animation instead of live action for a science communication video?
2D animation suits a healthcare company when the brief involves abstract scientific concepts that cannot be filmed directly, such as immune responses, cellular mechanisms, or multi-factor disease models. Live action suits briefs where the physical reality of the brand's product or environment is the proof: a clinical setting, a patient story, or a manufacturing facility. Additionally, 2D animation removes the need for location access, which makes it faster to brief for science education content. For pharma brands, the decision depends on whether the proof is visual reality or conceptual clarity.
A Note on the Craft
AstraZeneca's vaccine explainer works because the team mapped factor relationships before writing individual factor scripts. When briefing a multi-factor 2D animation science explainer, map the connections between your variables before writing any script sequence.
MyPromoVideos Production Desk, 2,000+ B2B videos madePeople Also Search For
Searches connected to the AstraZeneca vaccine effectiveness video and the 2D animation science communication decisions behind it.
- #2D animation explainer examples
- #vaccine science video
- #pharma 2D animation
- #health explainer video examples
- #science communication animation
- #healthcare explainer video production
- #2D animation for pharma brands
- #AstraZeneca animation style